Arcus Biosciences Inc (NYSE:RCUS) shares, rose in value on Friday, March 28, with the stock price down by -3.77% to the previous day’s close as strong demand from buyers drove the stock to $8.17.
Actively observing the price movement in the last trading, the stock closed the session at $8.49, falling within a range of $8.125 and $8.57. The value of beta (5-year monthly) was 1.356. Referring to stock’s 52-week performance, its high was $19.11, and the low was $8.02. On the whole, RCUS has fluctuated by -17.31% over the past month.
With the market capitalization of Arcus Biosciences Inc currently standing at about $864.72 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-24.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 154.46M, with a low estimate of 20M and a high estimate of 60M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 38.61M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RCUS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of RCUS currently trading nearly -11.76% and -26.57% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 30.17, while the 7-day volatility ratio is showing 5.89% which for the 30-day chart, stands at 5.63%. Furthermore, Arcus Biosciences Inc (RCUS)’s beta value is 1.51, and its average true range (ATR) is 0.57.
A comparison of Arcus Biosciences Inc (RCUS) with its peers suggests the former has fared considerably weaker in the market. RCUS showed an intraday change of -3.77% in last session, and over the past year, it shrunk by -50.93%%.
Data on historical trading for Arcus Biosciences Inc (NYSE:RCUS) indicates that the trading volumes over the past 10 days have averaged 0.84 and over the past 3 months, they’ve averaged 938.10K. According to company’s latest data on outstanding shares, there are 92.20 million shares outstanding.
Nearly 38.68% of Arcus Biosciences Inc’s shares belong to company insiders and institutional investors own 49.39% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 7.42 million shares as on 2025-03-14, resulting in a short ratio of 5.04. According to the data, the short interest in Arcus Biosciences Inc (RCUS) stood at 1263.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 6.47 million. The stock has fallen by -45.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RCUS stock heading into the next quarter.
